⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7155835 | 0.92 | — | — | |
| SCHEMBL17889889 | 0.89 | — | — | |
| SCHEMBL2228506 | 0.81 | — | — | |
| SCHEMBL484045 | 0.81 | MIF (0.68) | — | |
| SCHEMBL1854857 | 0.81 | — | — | |
| SCHEMBL7133119 | 0.78 | NAAA (0.74) | — | |
| SCHEMBL1233523 | 0.78 | NAAA (0.74) | — | |
| SCHEMBL330913 | 0.78 | NAAA (0.74) | — | |
| SCHEMBL2149597 | 0.78 | NAAA (0.74) | — | |
| SCHEMBL1999782 | 0.78 | NAAA (0.74) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9353082-B2 | Pharmaceutical compounds | BIAL—PORTELA & CA, S.A. (PT) | 2016-05-31 | — | — | US | claimed |
| CN-105399731-A | Pharmaceutical Compounds | BIAL PORTELA & CA SA | 2016-03-16 | — | — | CN | claimed |
| CN-102333568-B | Pharmaceutical compounds | BIAL—PORTELA & CA, S.A. (PT) | 2016-01-20 | — | — | CN | claimed |
| US-20120065191-A1 | PHARMACEUTICAL COMPOUNDS | BIAL - PORTELA & Cª, S.A. (PT) | 2012-03-15 | — | — | US | claimed |
| CN-102333568-A | Pharmaceutical compounds | BIAL PORTELA & CA SA | 2012-01-25 | — | — | CN | claimed |
| EP-2382012-A2 | PHARMACEUTICAL COMPOUNDS | Bial-Portela & CA, S.A. (PT) | 2011-11-02 | — | — | EP | claimed |
| WO-2010074588-A2 | PHARMACEUTICAL COMPOUNDS | BIAL - PORTELA & Cª, S.A. (PT) | 2010-07-01 | — | — | WO | claimed |
| WO-2023145203-A1 | POLYMER COMPOUND, REACTIVE COMPOUND, POLYMER CROSSLINKING AGENT, POLYMER MODIFIER, METHOD FOR FORMING A CROSSLINKED SECTION, METHOD FOR POLYMER MODIFICATION, AND METHOD FOR POLYMERIZING AND METHOD FOR DECOMPOSING POLYMER COMPOUND | 国立研究開発法人科学技術振興機構 | 2023-08-03 | — | — | WO | disclosed |
| EP-2606035-B1 | PROCES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS | BIAL - PORTELA & CA S A (PT) | 2017-09-06 | — | — | EP | disclosed |
| CN-106146429-A | The structure of isosulfocyanate precursor compound, prepare and apply | 天津国际生物医药联合研究院 | 2016-11-23 | — | — | CN | disclosed |
| US-9458111-B2 | Process for the synthesis of substituted urea compounds | BIAL—PORTELA & CA, S.A. (PT) | 2016-10-04 | — | — | US | disclosed |
| US-9353082-B2 | Pharmaceutical compounds | BIAL—PORTELA & CA, S.A. (PT) | 2016-05-31 | — | — | US | disclosed |
| CN-105399731-A | Pharmaceutical Compounds | BIAL PORTELA & CA SA | 2016-03-16 | — | — | CN | disclosed |
| EP-2606035-A1 | PROCES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS | BIAL - Portela & CA., S.A. (PT) | 2013-06-26 | — | — | EP | disclosed |
| US-20130123493-A1 | PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS | BIAL - PORTELA & CA, S.A. (PT) | 2013-05-16 | — | — | US | disclosed |
| US-20120065191-A1 | PHARMACEUTICAL COMPOUNDS | BIAL - PORTELA & Cª, S.A. (PT) | 2012-03-15 | — | — | US | disclosed |
| WO-2012015324-A1 | PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS | BIAL - PORTELA & CA, S.A. (PT) | 2012-02-02 | — | — | WO | disclosed |
| CN-102333568-A | Pharmaceutical compounds | BIAL PORTELA & CA SA | 2012-01-25 | — | — | CN | disclosed |
| EP-2382012-A2 | PHARMACEUTICAL COMPOUNDS | Bial-Portela & CA, S.A. (PT) | 2011-11-02 | — | — | EP | disclosed |
| WO-2010074588-A2 | PHARMACEUTICAL COMPOUNDS | BIAL - PORTELA & Cª, S.A. (PT) | 2010-07-01 | — | — | WO | disclosed |